Riggs Asset Managment Co. Inc. Adicet Bio, Inc. Transaction History
Riggs Asset Managment Co. Inc.
- $360 Million
- Q2 2025
A detailed history of Riggs Asset Managment Co. Inc. transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 1,122 shares of ACET stock, worth $1,110. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,122Holding current value
$1,110% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACET
# of Institutions
54Shares Held
53.1MCall Options Held
27.2KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA11.4MShares$11.3 Million0.25% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$8.14 Million0.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$7.47 Million0.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.75MShares$3.71 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$3.24 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $39.6M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...